NCT01711918View on ClinicalTrials.gov

Domperidone for the Treatment of Chronic Nausea and Vomiting Secondary to Gastroparesis

NACompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions
Patients With Gastroparesis Who Have Failed Standard Therapy
Interventions
DRUG

Domperidone

oral tablet; dose is 10mg per tablet given up to 3 times daily.

Trial Locations (1)

52242

University of Iowa Hospitals and Clinics, Iowa City

All Listed Sponsors
lead

Ron Schey

OTHER

NCT01711918 - Domperidone for the Treatment of Chronic Nausea and Vomiting Secondary to Gastroparesis | Biotech Hunter | Biotech Hunter